9th Annual Biomarkers Congress

Cancer Biology: University of Pennsylvania

Total Score People Score Events Score
66 49 44
Date Event Presentation Speakers
March 5, 2014 Targeted Anticancer Therapies Cell Cycle Targets: CDK4/6 Angela DeMichele
February 11, 2014 Jagelman/Turnbull International Colorectal Disease Symposium is underutilized Josh Bleier
Technical tricks to ensure a successful LIFT procedure Josh Bleier
November 11, 2013 Chromatin Structure and Function 2013 Reprogramming a developmentally controlled gene locus by forced chromatin looping Gerd A Blobel
Nucleosomes, Transcription Factors, and Enhancers Kenneth S. Zaret
April 6, 2013 AACR Annual Meetings Current Concepts on Emerging Targets in the Treatment of Melanoma Co-Chairpersons: Keith Thomas Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA, and Boris C. Bastian, UCSF Cardiovascular Research Institute, San Francisco, CA Keith T Flaherty
Change for the Worse: Premalignant Metaplasia in the Stomach, Esophagus, and Pancreas Chairperson: Steven D. Leach, Johns Hopkins University School of Medicine, Baltimore, MD Anil K Rustgi
Hypoxia-Induced Metastasis Chairperson: M. Celeste Simon, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA M. Celeste Simon
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX M. Celeste Simon
January 20, 2013 Tumor Invasion and Metastasis HIFs, hypoxia, and tumor progression M. Celeste Simon
Pathways in tumor dormancy and recurrence Lewis A. Chodosh
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium The Practical Use of Molecular Profiling – Ballroom A Angela DeMichele
Tumor Dormancy and Late Recurrences - Ballroom A Lewis A. Chodosh
Basic Science Forum – Ballroom B Molecular Imaging of Breast Cancer: Visualizing In Vivo Breast Cancer Biology Lewis A. Chodosh
October 4, 2012 14th Annual Lynn Sage Breast Cancer Symposium Can the Treatment of DCIS be Individualized? Lawrence Solin
September 13, 2012 International Society of Gastrointestinal Oncology GI Cooperative Groups Daniel G. Haller
Case 1: Small HCC in Patient with Viral Hepatitis Weijing Sun
March 15, 2012 3rd Quebec Conference on Therapeutic Resistance in Cancer Challenges of the I-SPY trials Angela DeMichele
February 20, 2012 Advances and Progress in Drug Design Accelerated determination of a LEAD Steven M. Albelda
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Welcome and Opening Remarks Anil K Rustgi
Day in Review Anil K Rustgi
Day in Review Anil K Rustgi
Day in Review Anil K Rustgi
November 18, 2011 16th Annual Perspectives In Thoracic Oncology Updates on thymoma Tracey L. Evans
Adjuvant therapy | State of the art in 2011 Tracey L. Evans
Controversies regarding the use of growth factor support in the treatment of advanced cancer Beth Eaby Sandy
Practical tips on the management of toxicities with EGFR and VEGFR inhibitors Beth Eaby Sandy
Continuation maintenance Tracey L. Evans
April 29, 2011 8th CURRENT TRENDS IN AORTIC AND CARDIOTHORACIC SURGERY The Latest Hybrid Techniques for the Repair of Complex Arch Aneurysms and Dissections Wilson Y. Szeto
March 27, 2011 Congress on Steroid Research Pre-receptor Regulation of the Androgen Receptor in Prostate Cancer Trevor R. Penning
March 25, 2011 Eighth International Symposium on Ovarian Cancer and Gynecologic Malignancies Immunotherapy George Coukos
March 3, 2011 Stem Cells, Development, and Cancer Tumor maintenance cells and therapy resistance Professor Meenhard Herlyn
January 12, 2011 "Nano in Cancer": Linking Chemistry, Biology, and Clinical Applications In Vivo Imaging tumors with targeted magnetic resonance contrast agents Andrew Tsourkas
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium Management of women with a highly penetrant predisposition to breast cancer: State of the art 2010 Susan M. Domchek
Balancing risks of deconditioning vs. weight-lifting for breast cancer survivors for Lymphedema Kathryn H. Schmitz
Models to mechanisms: Understanding tumor dormancy and breast cancer recurrence Lewis A. Chodosh
Basic Science Forum - Breast Cancer Recurrence and Tumor Dormancy – What is it? Does it matter? Lewis A. Chodosh
November 30, 2010 Tumor Immunology in Conjunction with the Cancer Immunology Working Group of the AACR Epigenetic targeting of Foxp3+ Tregs to enhance antitumor immunity Wayne Hancock
November 30, 2010 Tumor Immunology: Basic and Clinical Advances in Conjunction with the Cancer Immunology Working Group of the AACR Epigenetic targeting of Foxp3+ Tregs to enhance antitumor immunity Wayne Hancock
November 8, 2010 Cancer Metabolism Hypoxic effects on cancer cell metabolism M. Celeste Simon
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research Pharmacogenetics of nicotine dependence treatment: Implications for targeted therapy Caryn Lerman
Novel strategies for the early detection of solid cancers through vascular biomarkers George Coukos
Pheochromocytoma and paraganglioma Katherine L. Nathanson
Concurrent Sessions 11 : Advances in the Genetics and Treatment of Cancer Susceptibility Syndromes Katherine L. Nathanson
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases David Artis
October 27, 2010 Colorectal Cancer: Biology to Therapy Welcome and Opening Remarks Anil K Rustgi
Dampening of TGFbeta responses by Myc-regulated microRNAs: Implications for colon cancer angiogenesis Andrei Thomas-Tikhonenko
Imaging colon cancer targets for therapy W S El-Deiry
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Regulation of Splicing Kristin W. Lynch
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities An epidemiologist’s perspective Timothy R. Rebbeck
Educational Session 1: The Whether, How, and When of Race in Cancer Disparities Research: Three Viewpoints Timothy R. Rebbeck
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved An epidemiologist’s perspective Timothy R. Rebbeck
The Whether, How, and When of Race in Cancer Disparities Research: Three Viewpoints Timothy R. Rebbeck
September 25, 2010 The Management of Women with Chronic Immune Disorders in the Era of Biologics Putting risk into perspective: A case-based discussion Abby Van Voorhees
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Necdin regulation by Nm23-H1 and EBNA3C: Insights from a virus Erle S. Robertson
August 23, 2010 The Ubiquitin Drug Discovery & Diagnostics Conference TBA Dan Vogl
August 18, 2010 Challenges in Pre-Clinical & Clinical Development - Top 5 Challenges in Vaccines & Immunotherapeutics An Integrative Paradigm for Biomarker Development in Immunotherapy Clinical Trials-Lessons Learned and Future Directions Michael Kalos
Opening Remarks Bruce L. Levine
Chairperson’s Remarks Bruce L. Levine
Panelists: Michael Kalos
Moderator: Bruce L. Levine
July 11, 2010 Translational Cancer Medicine 2010 (USA) Genetic testing from breast and ovarian cancer: From risk assessment to therapeutic targeting Susan M. Domchek
HIFs, hypoxia, and tumor progression M. Celeste Simon
June 20, 2010 Human Variation: Cause and Consequence Genetics of human gene expression Vivian Cheung
May 7, 2010 Great Debates and Updates in Breast Cancer Debate: Should we recommend post mastectomy radiation to all patients with node positive breast cancer? Lawrence J. Solin
Debate: Should all patients undergo MRI screening prior to surgery? Are all MRI scans the same? Lawrence J. Solin
December 4, 2009 2009 Advances in Inflammatory Bowel Diseases Session I A: Plenary Session: State of the art in using biologics in IBD – I | 1 Gary R. Lichtenstein
Session IV A: Advances in the management of IBD – I | 1 James D. Lewis
Risk and surveillance of non-GI malignancies in IBD patients James D. Lewis
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Weijing Sun
Case Presentation 1: Preoperative Therapy Weijing Sun
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Expert Panel Discussion: Commonalities and Lessons Learned from Infectious Disease and Cancer Immunotherapy and Vaccine/Immunotherapy Development Programs Bruce L. Levine
Proactive Risk Management During Development: Ways to Improve the Probability of Success Paul Coplan
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Novel Approaches to Adjuvanting the Immune Potency of DNA Vaccines D B Weiner
February 19, 2009 HKEC Training Centre for Healthcare managment & Clinical Techology Live demonstrations (parallel theatres) William MENG
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting Concurrent C: Joint Degeneration in Mice Lacking Adequate Perlecan Levels Kathryn D. Rodgers
Matrix Elasticity Directs Differentiation & De-Differentiation Dennis E. Discher
Concurrent N: Pre and Postsynaptic Development in Zebrafish Michael , Granato
Concurrent O: Collagen X is required for proper hematopoietic development Elizabeth Sweeney,
November 12, 2008 Invited Session SESSION 10 – Organismal and Cellular Phenomics of Breast Cancer Susceptibility Genes Taking advantage of the mutants: Targeted therapeutics. W S El-Deiry
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow CAN CIRCULATING TUMOR CELLS BE A PREDICTIVE MARKER FOR TREATMENT OF COLON CANCER? Neal J. Meropol
IMMUNE THERAPY FOR OVARIAN CANCER: ARE WE READY TO LAUNCH? George Coukos
May 30, 2008 ASCO Annual'08 Meeting clinical trials-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
patient and survivor care-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
practice management and information technology-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
meet the professor sessions-- Optimizing Your Clinical Trials Program (M18) Deborah Bruner
December 1, 2007 47TH American Socieity of Cell Biology At the Limits: Optical Methods for Single Molecules, Cells, and Organisms John M Murray
Symposium VI Ballrooms A/B/C Dennis E. Discher
Stem Cell Force Generation and Differentiation. Dennis E. Discher
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.